EW Healthcare Partners

About The Fund

EW Healthcare Partners, founded in 1985 and headquartered in New York, New York, operates as a private equity firm with a strategic focus on the healthcare sector. With an emphasis on equity investments, they channel their expertise into companies that are situated at the expansion, later stage, or participating in PIPE transactions. They are a venture capital fund with assets under management totaling approximately 3 billion USD. The firm has set a minimum investment threshold of 20 million USD and a maximum of 80 million USD. EW Healthcare Partners invests specifically in the fields of pharmaceuticals, medical devices, healthcare services, and healthcare information technology, sectors which are primed for growth due to the increasing elderly population who demand enhanced healthcare solutions, cutting-edge technology, and superior healthcare products. By partnering with highly-experienced management teams, their goal is to cultivate leading businesses in the healthcare industry. Their portfolio showcases a range of investments, such as Abiomed, an innovator of the world's smallest and least invasive micro blood pump, Biotoscana, a specialty pharmaceutical company with a focus on oncology and critical care medications in Latin America, Bioventus, a firm specializing in orthobiologics for bone growth stimulation and joint pain therapy, and EUSA Pharma, a specialty pharmaceutical company operating across both sides of the Atlantic with a focus on oncology and critical care. EW Healthcare Partners prides itself on offering more than just capital; they see themselves as collaborative partners, sharing strategic insights, industry connections, and practical guidance to foster the growth and success of their portfolio companies. Their website features testimonials and endorsements from management executives of their portfolio companies, illustrating the firm's commitment to building successful partnerships and to their active role in driving company growth.